Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

Sano Minoru

Nipro Corporation

Medtechwest is involved in the development and promotion of medical technology innovations, including dental implants that generate electricity and surgical procedures using augmented reality.

Metric
Company Name	Nipro Corporation	Medtechwest
Symbol	8.09K
MSH ID	JP:CO:NIPRO	SE:MEDTECHWEST
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Devices
Country	JP	SE
Stage
Employee Count	38.12K
Website	nipro.co.jp	medtechwest.se
LinkedIn
Founders

Metric
Market Cap	1.41B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	3.91B
Revenue (LTM)
Revenue (NTM)
Gross Profit	1.14B
EBITDA	541.60M
Operating Income	148.96M
Net Income	74.09M
EPS	0.45
Diluted EPS	0.40
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.30
Operating Profit Margin	0.05
EBITDA Margin	0.14
Net Profit Margin	0.02
Return on Equity	0.05
Return on Assets	0.01
Return on Capital Employed	0.04

8086

JP:CO:NIPRO

Nipro Corporation

Last Close

1,367.50

14/02 06:30

Market Cap

210.64B

Beta: -

Volume Today

390.40K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	26.63
P/B Ratio	0.93
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.40
EV Multiple	-4.44

Metric
Days Sales Outstanding	108.95
Days Payables Outstanding	75.70
Days Inventory Outstanding	207.47
Operating Cycle	319.69
Cash Conversion Cycle	245.85
Asset Turnover	0.53

Metric
Operating Cash Flow	488.17M
Free Cash Flow	-140.52M
Cash Flow to Debt	0.19
Operating Cash Flow/Sales	0.19
Free Cash Flow Yield

Metric
Cash & Equivalents	664.71M
Accounts Receivable	52.32M
Inventory	1.51B
Goodwill	104.09M
Debt to Capitalization	0.72
Debt to Assets	0.58
Current Ratio	1.51
Quick Ratio	0.82

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue